A multicenter descriptive analysis of 270 men with frontal fibrosing alopecia and lichen planopilaris in the United States

By sjmartinez • March 22, 2023

Pathoulas JT, Flanagan KE, Walker CJ, Collins MS, Ali S, Pupo Wiss IM, Cotsarelis G, Milbar H, Huang K, Mostaghimi A, Scott D, Han JJ, Lee KJ, Hordinsky MK, Farah RS, Bellefeuille G, Raymond O, Bergfeld W, Ranasinghe G, Shapiro J, Lo Sicco KI, Gutierrez D, Ko J, Mirmirani P, Mesinkovska N, Yale KL, Goldberg LJ, Tosti A, Gwillim EC, Goh C, Senna MM. A multicenter descriptive analysis of 270 men with frontal fibrosing alopecia and lichen planopilaris in the United States. J Am Acad Dermatol. 2023 Apr;88(4):937-939. doi: 10.1016/j.jaad.2022.10.060. Epub 2022 Nov 15. PMID: 36396001.

Tags: AGA, Alopecia, androgenetic alopecia, autoimmune, beard loss, body hair, cicatricial, cicatricial alopecia, Dermatology, dermatology, eyebrows, facial hair, FFA, fibrosing, fibrosis, frontal fibrosing alopecia, hair, hair loss, hair loss in men, hair specialists, itch, lichen planopilaris, loss, LPP, male pattern hair loss, men, misdiagnosis, MPHL, multicenter, pattern hair loss, PHL, pruritus, Publications, retrospective review, scalp itch, scalp symptoms, scarring, scarring alopecia, sideburns, specialty hair clinic, sunscreen

Diagnosis and management of anti-p200 pemphigoid: Perspectives of international dermatologists with expertise in immunobullous diseases

Kasperkiewicz M, Xu J, Thapa M, Culton DA, Curman P, Hashimoto T, Meijer JM, Patsatsi A, Tomayko MM, Lehman JS, Schmidt E. Diagnosis and management[...]

Real-World Effectiveness and Safety of 12 Months of Tralokinumab in Patients with Atopic Dermatitis

Armstrong AW, Ameen A, Ferrucci S, Pereyra-Rodríguez JJ, Cork MJ, Rubin C, Jarell A, Narcisi A, Becherel PA, Beecker J, Festini T, Vittrup I, Vinther[...]

Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a focused narrative review

Armstrong AW, Strober BE, Liu CM, Cather JC, Merola JF, Lebwohl MG. Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a[...]